Vishnu Chemicals - Is Growth sustainable?

Case study – Will future be more consistent?

When I discussed Vishnu Chemicals with my investor friends, a very important question cropped up in many discussions.

Vishnu Chemicals’ performance till FY21 was subdued & inconsistent for past so many years and it improved only from FY22. Is something wrong with the company’s business or execution capabilities/integrity of the management? Is the company riding on only favourable external factors and improvement is temporary? Should one buy such stock for very long term?

Deep dive into the valuepickr forum and various other public information suggest that while management had hunger & dedication to grow; high debt level with high interest rates and fund crunch were big constraint in earlier years.

I appreciate that the management did not stop making efforts to change the things, despite fund crunch. Investment in Carbon Di-oxide recovery plant became a game changer move. It was delayed but when it became operational it changed the fortunes as cost of production came down. The company also gradually diversified into value-add products and added new user industries. The company set-up barium business (in JV earlier which was acquired by Vishnu later on) but high quality raw material availability was an issue. Not only raw material availability eased out later on, VCL recently acquired Ramadas Minerals Pvt Ltd, through which it can convert low-grade barytes into a superior-grade.

These efforts along with favourable industry scenario helped the company in changing its orbit. With the cash accruals in last few years along with QIP issue, gearing level is at comfortable level now. Improved balance sheet and credit rating will help in reducing interest rates. There seems to be further efforts on expanding capacity, adding derivative products, improve barium business and bring down costs on continuous basis. All this make me believe that past is behind, major issue is resolved and company should do well in future more consistently.

In my view, CFO/EBITDA, end result of capex, management remuneration, related party transactions are few important parameters to check fund leakage. In last 10 years, cumulative CFO/EBITDA is 0.62x despite 3x increase in revenue (which results in incremental working capital requirement), capex of Rs.600 cr in this period seems to be fruitful and management remuneration is reasonable. In terms of related party transactions, the company partly outsources transportation to a group company but amount is less than 0.3% of revenue per annum. Also, promoters have given interest free unsecured loans and also forgone part of interest on preference shares. Overall, the company looks clean on these parameters.

While I generally avoid companies with inconsistent performance for a prolonged period and use past performance as an important benchmark for future, here I have taken deviation due to above mentioned reasons. I believe that one should have some flexibility in his investment framework, particularly when there is strong logic to do that. Only time will tell if my logic & analysis is right and I will use the outcome as a learning for future.

Disc: Invested. I am not SEBI registered Advisor/Analyst. My view may be positively biased. I am not suggesting any investment action. The information provided above is for education purpose only.

20 Likes

Financial Performance and highlights from the Q1, FY25 investor presentation.

Q1 FY25 Highlights

  • Operating Revenues: ₹338.8 crore, a 13% increase year-over-year (YoY) from ₹300.7 crore in Q1 FY24.
  • EBITDA: ₹55.6 crore, up 9% YoY, with a margin of 16.4%, slightly down from 17.0% in the previous year.
  • Profit After Tax (PAT): ₹30.5 crore, a 6% increase YoY, with a PAT margin of 9.0%.
  • Production Volumes: Achieved all-time high production volumes, indicating strong operational efficiency.
  • Sales Mix: Balanced domestic and export sales at a 50:50 ratio, with a notable increase in sales volumes for Barium Chemicals by 11.1% YoY.

Comparison with Previous Quarters

  • Sequential Growth: PAT has shown growth for the last two quarters, with a 10% increase from Q4 FY24 (₹27.7 crore).
  • Cost Management: The company has managed to increase the realizations of finished goods to offset rising freight and raw material costs, demonstrating resilience in its business model despite external pressures.

Future Prospects

Market Trends

Vishnu Chemicals operates in sectors with promising growth drivers, including:

  • Industrial Growth: Increasing industrial activity in India is expected to drive demand for performance chemicals, particularly in pharmaceuticals, automobiles, and construction.
  • Demographic Shifts: The expanding middle class in India is likely to boost consumption across various sectors, further benefiting the company’s product lines.
  • Premiumization: There is a growing trend towards premium products, which aligns with Vishnu Chemicals’ focus on quality and innovation in specialty chemicals.

Strategic Focus

  • Innovation and R&D: The management emphasizes continuous improvement and innovation, which is critical for maintaining competitive advantage and expanding market share.
  • Geographic Expansion: The company is actively exploring new markets, particularly in Barium chemistry, which could enhance its revenue streams.

Disclaimer: Not invested, Tracking only. Not a reco., to buy or sell.

1 Like

Key Takeaways from 31st AGM held on 27-Sep-2024

• Global customers are looking at India as reliable partner in the chemical space because of multiple reasons
• The company produces chromium and barium chemicals which are irreplaceable products in multiple industries due to unique characteristics
• Export and domestic sales mix has been historically around 50: 50 and currently around 45:55
• The company does not have domestic competitors having material scale. Competition in exports as well as domestically is from competitors based out of Turkey, Russia, USA, South Africa and Kazakhstan
• The company has flexible product mix and has been working on process innovations
• The company has been working on both forward and backward integration
• It has completed brownfield expansion for precipitated barium sulfate, which is used in multiple industries including power coating and battery. It’s an import substitute product and has achieved 60% utilization in first 12 months itself
• in FY24, the company acquired Ramadas Minerals for backward integration in barium segment. It has baryte beneficiation plant based on green technology and baryte produced from this plant is internally used as raw material for barium products. The plant is running at 90% production level now.
• In the current fiscal year, the company has acquired Jayansree Pharma to manufacture strontium carbonate. It’s a new (related) product and import substitute. It finds application in electronics and EV battery industry. Trial run and test marketing is completed and commercial production is expected from April 2025. This is expected to contribute about Rs.100 crore revenue in FY26, which is scalable to Rs.200 crore over a period.
The company expects its revenue to grow by minimum at 20% CAGR over the next 3-4 years. Levers of growth are utilization of existing capacity (current utilization level of about 75%) and products such as strontium carbonate, sodium sulphide, chromium metals, special solvents organic chemicals which they are adding.
• Red sea issue has resulted in shipping challenges and higher transportation cost. Certain customers have also asked to delay dispatches. Inventory days have also increased due to this. The company is working on solutions and also exporting to other countries, which are not impacted by this.

Disc: Invested. I am not SEBI registered Advisor/Analyst. My view may be positively biased. I am not suggesting any investment action. The information provided above is for education purpose only.

18 Likes

Thanks for sharing AGM notes , very helpful, thanks

1 Like

As I started reading more about the company, I found it to be strong in terms of its growth and long-term potential. However, I noticed that the company’s Chairman, who is also the founder, is a key member of the board, along with other family members holding significant positions, including the Joint Managing Director and a Non-Executive Director. Additionally, I see that the Chairman and his family are the only promoters of the company, with the Chairman himself holding nearly 92% of the shares. Isn’t it a very big red flag?
Board of director.
image
Promoters
image

1 Like

In promoter-led companies, Chairman and his family WILL have the most number of shares. How is that a red flag?

1 Like

My main emphasis was on the point that the chairperson and respective executives (the family members) are all part of the board members. They can influence decisions when required.

They are the promoters. They are the majority share holders. Obviously they should have power to “influence” decisions. Whats wrong with that? are you implying Mukesh Ambani shouldn’t have control over Reliance board? RK Damani shouldn’t influence Dmart board?

As per SEBI regulations, at least half of the board of directors shall comprise of independent directors, where the listed entity does not have a regular non-executive chairperson.
Vishnu Chemicals’ board comprises of more than 50% independent directors, which is in full compliance with the regulations. Moreover, CMD’s son as Joint MD gives clarity on succession.

As per the best international corporate governance practices, role of chairman and managing director should be split. However, most of the family owned companies in India have not done it. Also, this is more important for larger companies. While this may not be the best CG practice as per global norms, but well inline with the practical aspects in India. This is not a red flag situation.

As per the best international CG practices, shareholding should not be concentrated. However, many investment gurus give significant importance to promoters’ skin in the game with majority shareholding. In my opinion, many Indian companies with significant promoter stake have done very well at the same time there are only handful of Indian companies with dispersed shareholding having such track record.

8 Likes

That’s an amazing perspective,Thanks for your input.

Proposed acquisition of Chrome Mining Complex

Vishnu Chemicals has signed a definitive agreement to acquire a Chrome Mining Complex in South Africa, comprising of chrome mine along with Processing, Mining and Infrastructure assets for a total consideration of approx Rs.84 cr. The acquisition is expected to be completed within 12 months, subject to closing conditions and regulatory approvals.

Once acquisition is completed and mine & processing plant are restored, this is expected to provide benefit in terms of backward integration and stable supply of chrome ore raw material.

Vishnu has been gradually expanding its existing manufacturing capacities and also expanding capabilities through both forward and backward integration, via organic and inorganic routes. This is second inorganic initiative in the current financial year. While the hunger to grow and desire to make the business more robust is visible; delivery of results through these initiatives is to be seen, which is very critical from long term perspective.

Disc: Invested. I am not SEBI registered Advisor/Analyst. My view may be biased. I am not suggesting any investment action. The information provided above is for education purpose only.

6 Likes

Q2FY25 - Unexciting performance and near-term outlook, long-term story intact

• On a consolidated basis, operating revenue grew by 12% Y-o-Y to Rs. 343.8 crores in Q2 FY '25. EBITDA degrowth of 2% to 45.1 crores, PAT degrowth of 5% to Rs.22.8 crores
• The company is facing intense competition in Chromium exports business and higher freight cost has added to the issue.
• In the Barium segment, the company saw increased volume of the Barium sulfate product and better profitability despite increase in raw material cost
• Margin was impacted due to increased raw material cost (Chrome ore and Barytes), increased shipping cost and higher fixed costs due to scheduled maintenance taken during the quarter
• While the company is expecting significant volume growth in barium segment, challenges faced in chromium segment can take couple of quarters time to subside. Hence, profit growth in H2FY25 may not be robust
• Jayansree Pharma, which was acquired by the company in current financial year, would start manufacturing Strontium carbonate from Q1FY26. It’s an import substitute product and right now there is no other player that’s producing this in India. At full operating level, considering a 10,000-ton production two years down the line, revenue could be 140 to 150 crores.
• Chrome Mining Complex acquired in Africa for backward integration, is expected to commence operations in next 6-12 months’ time (Reaching to full operating level may take two years from now). This should provide significant cost competitiveness, which in turn should also help in volume growth and better profitability in chromium segment.
• The company is planning to increase Precipitated Barium Sulfate capacity from 30000 MTPA currently to 50k to 60k MPTA in next 2 years. The company is also looking at launching another valueadded product Chromium metal during Q1FY26

Disc: Invested. I am not SEBI registered Advisor/Analyst. My view may be biased. I am not suggesting any investment action. The information provided above is for education purpose only.

4 Likes

Good results from Vishnu.

Link to results:
https://www.bseindia.com/xml-data/corpfiling/AttachLive/691948b3-4183-4b77-a806-b43ff12ade2d.pdf

1 Like

Vishnu Chemicals Initiating Coverage_050225_Others.pdf (2.1 MB)

4 Likes

Good Article on Vishnu Chemicals. Looks like the expansion and integration all are in progress.
Q4 numbers should be interesting
.

2 Likes

Interesting to see traction building up in Vishnu Chemicals.
Along With recent institution coverage potentially aligning with earning improvement and reasonable multiples (~25x PE), could be interesting.